Safety, tolerability, PK and PD of Ulimorelin (QCL117426)

• Research type

  Research Study

• Full title

  Safety, tolerability, PK and PD of Ulimorelin (QCL117426)

• IRAS ID

  178406

• Contact name

  Joyce James

• Sponsor organisation

  Lyric Pharmaceutical Inc.

• Eudract number

  2015-001257-32

• Duration of Study in the UK

  0 years, 4 months, 29 days

• Research summary

  Research summary not yet available

• REC name

  Scotland A REC

• REC reference

  15/SS/0067

• Date of REC Opinion

  29 Apr 2015

• REC opinion

  Unfavourable Opinion